PE89199A1 - Composicion farmaceutica de tiazolidinadiona y un inhibidor de alfa glucosidasa para el tratamiento de la diabetes - Google Patents
Composicion farmaceutica de tiazolidinadiona y un inhibidor de alfa glucosidasa para el tratamiento de la diabetesInfo
- Publication number
- PE89199A1 PE89199A1 PE1998000536A PE00053698A PE89199A1 PE 89199 A1 PE89199 A1 PE 89199A1 PE 1998000536 A PE1998000536 A PE 1998000536A PE 00053698 A PE00053698 A PE 00053698A PE 89199 A1 PE89199 A1 PE 89199A1
- Authority
- PE
- Peru
- Prior art keywords
- treatment
- diabetes
- tiazolidinadiona
- pharmaceutical composition
- glucosidase inhibitor
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 3
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 title 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 abstract 1
- -1 AMINO Chemical class 0.000 abstract 1
- 229940122355 Insulin sensitizer Drugs 0.000 abstract 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 abstract 1
- IBAQFPQHRJAVAV-ULAWRXDQSA-N Miglitol Chemical compound OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO IBAQFPQHRJAVAV-ULAWRXDQSA-N 0.000 abstract 1
- 229960002632 acarbose Drugs 0.000 abstract 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 abstract 1
- 108010028144 alpha-Glucosidases Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- YZFWTZACSRHJQD-UHFFFAOYSA-N ciglitazone Chemical compound C=1C=C(CC2C(NC(=O)S2)=O)C=CC=1OCC1(C)CCCCC1 YZFWTZACSRHJQD-UHFFFAOYSA-N 0.000 abstract 1
- 229950000269 emiglitate Drugs 0.000 abstract 1
- NWWORXYTJRPSMC-QKPAOTATSA-N ethyl 4-[2-[(2r,3r,4r,5s)-3,4,5-trihydroxy-2-(hydroxymethyl)piperidin-1-yl]ethoxy]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1OCCN1[C@H](CO)[C@@H](O)[C@H](O)[C@@H](O)C1 NWWORXYTJRPSMC-QKPAOTATSA-N 0.000 abstract 1
- 229960001110 miglitol Drugs 0.000 abstract 1
- HYAFETHFCAUJAY-UHFFFAOYSA-N pioglitazone Chemical compound N1=CC(CC)=CC=C1CCOC(C=C1)=CC=C1CC1C(=O)NC(=O)S1 HYAFETHFCAUJAY-UHFFFAOYSA-N 0.000 abstract 1
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
CARACTERIZADA PORQUE COMPRENDE a)UN SENSIBILIZADOR A INSULINA TAL COMO 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]-BENCIL]TIAZOLIDINA-2,4-DIONA UTILIZANDOSE DE 2 mg A 12 mg, O TROGLITAZONA, CIGLITAZONA, PIOGLITAZONA, ENGLITAZONA Y b)UN AGENTE ANTIHIPERGLUCEMICO INHIBIDOR DE ALFA-GLUCOSIDASA TAL COMO ACARBOSA, EMIGLITATO O MIGLITOL. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y PARA LAS CONDICIONES ASOCIADAS A LA DIABETES MELLITUS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712865.6A GB9712865D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| GBGB9806708.5A GB9806708D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE89199A1 true PE89199A1 (es) | 1999-10-23 |
Family
ID=26311746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1998000536A PE89199A1 (es) | 1997-06-18 | 1998-06-18 | Composicion farmaceutica de tiazolidinadiona y un inhibidor de alfa glucosidasa para el tratamiento de la diabetes |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0975343A1 (es) |
| JP (1) | JP2001523271A (es) |
| KR (1) | KR20010013845A (es) |
| CN (1) | CN1274282A (es) |
| AP (1) | AP9901720A0 (es) |
| AR (2) | AR014881A1 (es) |
| AU (1) | AU8799998A (es) |
| BG (1) | BG103966A (es) |
| BR (1) | BR9810186A (es) |
| CA (1) | CA2294134A1 (es) |
| CO (1) | CO4940453A1 (es) |
| DZ (1) | DZ2519A1 (es) |
| EA (1) | EA200000040A1 (es) |
| IL (1) | IL133138A0 (es) |
| MA (1) | MA26510A1 (es) |
| NO (1) | NO996270D0 (es) |
| NZ (1) | NZ501345A (es) |
| OA (1) | OA11631A (es) |
| PE (1) | PE89199A1 (es) |
| PL (1) | PL337577A1 (es) |
| SK (1) | SK179499A3 (es) |
| TR (1) | TR199903072T2 (es) |
| UY (1) | UY25051A1 (es) |
| WO (1) | WO1998057635A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| RS50114B (sr) | 1999-04-23 | 2009-03-25 | Smithkline Beecham P.L.C., | Novi polimorfni oblik 5-/4-/2-(n-metil- n-(2-piridil)amino/ etoksi/benzil/ tiazolidin-2,4-dion, soli maleinske kiseline |
| US20030045553A1 (en) | 2001-04-04 | 2003-03-06 | Bussolari Jacqueline C. | Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| WO2002080935A1 (en) | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
| JP2004067575A (ja) * | 2002-08-06 | 2004-03-04 | Yaizu Suisankagaku Industry Co Ltd | 糖尿病治療薬効果促進剤 |
| CN101121004B (zh) * | 2006-08-08 | 2010-07-21 | 鲁南制药集团股份有限公司 | 含有胰岛素增敏剂和米格列醇的药物组合物 |
| CN101584705B (zh) * | 2008-05-24 | 2010-10-27 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
| CN101584688B (zh) * | 2008-05-24 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种治疗糖尿病及其并发症的药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900435A (en) * | 1991-08-26 | 1999-05-04 | Pharmacia & Upjohn Company | Composition, food product and uses of 3-guanidinopropionic acid |
| US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1998
- 1998-06-15 CA CA002294134A patent/CA2294134A1/en not_active Abandoned
- 1998-06-15 TR TR1999/03072T patent/TR199903072T2/xx unknown
- 1998-06-15 WO PCT/EP1998/003691 patent/WO1998057635A1/en not_active Ceased
- 1998-06-15 PL PL98337577A patent/PL337577A1/xx unknown
- 1998-06-15 KR KR1019997011866A patent/KR20010013845A/ko not_active Withdrawn
- 1998-06-15 AU AU87999/98A patent/AU8799998A/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001720A patent/AP9901720A0/en unknown
- 1998-06-15 JP JP50375699A patent/JP2001523271A/ja not_active Ceased
- 1998-06-15 IL IL13313898A patent/IL133138A0/xx unknown
- 1998-06-15 SK SK1794-99A patent/SK179499A3/sk unknown
- 1998-06-15 EP EP98939513A patent/EP0975343A1/en not_active Withdrawn
- 1998-06-15 EA EA200000040A patent/EA200000040A1/ru unknown
- 1998-06-15 CN CN98806319A patent/CN1274282A/zh active Pending
- 1998-06-15 BR BR9810186-2A patent/BR9810186A/pt not_active IP Right Cessation
- 1998-06-17 AR ARP980102885A patent/AR014881A1/es unknown
- 1998-06-17 DZ DZ980129A patent/DZ2519A1/xx active
- 1998-06-17 AR ARP980102882A patent/AR013352A1/es unknown
- 1998-06-17 MA MA25121A patent/MA26510A1/fr unknown
- 1998-06-18 PE PE1998000536A patent/PE89199A1/es not_active Application Discontinuation
- 1998-06-18 UY UY25051A patent/UY25051A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034648A patent/CO4940453A1/es unknown
- 1998-07-15 NZ NZ501345A patent/NZ501345A/en unknown
-
1999
- 1999-12-08 BG BG103966A patent/BG103966A/bg unknown
- 1999-12-17 NO NO996270A patent/NO996270D0/no not_active Application Discontinuation
- 1999-12-17 OA OA9900295A patent/OA11631A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9810186A (pt) | 2000-08-08 |
| KR20010013845A (ko) | 2001-02-26 |
| TR199903072T2 (xx) | 2000-07-21 |
| IL133138A0 (en) | 2001-03-19 |
| NO996270L (no) | 1999-12-17 |
| CN1274282A (zh) | 2000-11-22 |
| CA2294134A1 (en) | 1998-12-23 |
| SK179499A3 (en) | 2000-11-07 |
| JP2001523271A (ja) | 2001-11-20 |
| OA11631A (en) | 2004-11-22 |
| EP0975343A1 (en) | 2000-02-02 |
| NZ501345A (en) | 2001-10-26 |
| AP9901720A0 (en) | 1999-12-31 |
| NO996270D0 (no) | 1999-12-17 |
| WO1998057635A1 (en) | 1998-12-23 |
| BG103966A (bg) | 2000-07-31 |
| MA26510A1 (fr) | 2004-12-20 |
| CO4940453A1 (es) | 2000-07-24 |
| AR014881A1 (es) | 2001-04-11 |
| AR013352A1 (es) | 2000-12-27 |
| EA200000040A1 (ru) | 2000-08-28 |
| AU8799998A (en) | 1999-01-04 |
| PL337577A1 (en) | 2000-08-28 |
| UY25051A1 (es) | 2000-09-29 |
| DZ2519A1 (fr) | 2003-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE83199A1 (es) | Composicion farmaceutica de tiazolidinadiona y biguanida para el tratamiento de la diabetes | |
| UY25713A1 (es) | Método para tratar diabetes empleando un inhibidor ap2 y combinación. | |
| TR200102874T2 (tr) | Heterosiklik ierikli bifenil AP2 nleyicileri ve metot. | |
| PE99599A1 (es) | Composicion farmaceutica para el tratamiento de la diabetes | |
| PE89199A1 (es) | Composicion farmaceutica de tiazolidinadiona y un inhibidor de alfa glucosidasa para el tratamiento de la diabetes | |
| PE104499A1 (es) | Composicion farmaceutica de tiazolidindiona e insulina para el tratamiento de la diabetes | |
| PE99499A1 (es) | Composicion farmaceutica para el tratamiento de la diabetes | |
| PE99799A1 (es) | Composicion farmaceutica para el tratamiento de la diabetes | |
| PE108199A1 (es) | Composicion farmaceutica de tiazolidindiona y sulfonilurea | |
| HK1041201A1 (zh) | 貝塔激動劑和抗糖尿病製劑的配伍 | |
| EA200300005A1 (ru) | Соль тиазолидиндиона для лечения сахарного диабета | |
| CY1107767T1 (el) | Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο | |
| BR0309375A (pt) | Tratamento de sìndrome metabólica | |
| TR200000957T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı | |
| ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
| ECSP982592A (es) | Nuevo metodo de tratamiento v | |
| ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
| ES2174748B1 (es) | Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos. | |
| ECSP982534A (es) | Nuevo metodo de tratamiento | |
| ES2083319B1 (es) | Monohidrato de clorhidrato de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil)-6-cloro-1,3-dihidro-2h-indol-2-ona. | |
| UY26341A1 (es) | Método para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condición asociada con diabetes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |